Imunon (IMNN) Set to Announce Quarterly Earnings on Thursday

Imunon (NASDAQ:IMNN) is set to post its quarterly earnings results before the market opens on Thursday, November 7th. Analysts expect Imunon to post earnings of ($0.37) per share for the quarter.

Imunon (NASDAQ:IMNN) last issued its quarterly earnings results on Wednesday, August 14th. The company reported ($0.51) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.04. On average, analysts expect Imunon to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Imunon Price Performance

IMNN traded up $0.01 during trading hours on Tuesday, hitting $0.99. 198,227 shares of the company’s stock were exchanged, compared to its average volume of 993,945. Imunon has a 12-month low of $0.48 and a 12-month high of $3.65. The firm has a 50 day moving average of $1.03 and a 200 day moving average of $1.21.

Analyst Ratings Changes

IMNN has been the topic of a number of recent research reports. EF Hutton Acquisition Co. I raised shares of Imunon to a “strong-buy” rating in a report on Monday, September 23rd. HC Wainwright reaffirmed a “buy” rating and issued a $14.00 target price on shares of Imunon in a report on Thursday, August 15th.

About Imunon

Imunon, Inc, a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company’s lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development.